[Remote] Director, Scientific Communications at Orca Bio

Menlo Park, California, United States

Orca Bio Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Scientific CommunicationsMSL MaterialsMedical AffairsPublicationsContinuing Medical EducationBiotechnologyCell TherapiesStrategic PlanningTraining

Questions & Answers

Common questions about this position

What education and experience are required for the Director of Scientific Communications role?

An advanced clinical/scientific degree such as Pharm.D. or Ph.D. is required, along with 8+ years of experience in Medical Affairs or relevant pharmaceutical industry experience, and 5+ years in medical/scientific communications and/or publications.

What is the travel or location policy for this position?

Travel is required as needed to Orca Bio HQ in Menlo Park, CA, and local candidates are preferred.

What are the main responsibilities of the Director of Scientific Communications?

Key duties include establishing the Scientific Communications capability, leading annual strategic plans, creating scientific tools and materials, overseeing publications and building a team, managing budgets, and supporting training and congress activities.

Is there information on salary or compensation for this role?

This information is not specified in the job description.

What makes a strong candidate for this position?

Strong candidates will have an advanced degree like Pharm.D. or Ph.D., extensive Medical Affairs experience, specific expertise in scientific communications and publications, and preferably experience in hematology/oncology.

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI